PTAB
IPR2016-01563
Mylan Pharmaceuticals Inc. v. Boehringer Ingelheim Pharmaceuticals Inc.
General
Filed
08/10/16
Institution02/03/17
FWD07/18/17
Close07/18/17
StatusTerminated
OutcomeUnpatentable
USPTOIPR2016-01563
Petitioner
Respondent
Attorney
Name | Ratings |
---|---|
L5 A | |
L5 A | |
L5 A | |
L5 A |
No Attorneys